Mirae Asset Global Investments Co., Ltd. Ocular Therapeutix, Inc Transaction History
Mirae Asset Global Investments Co., Ltd.
- $20 Billion
- Q2 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 4,624 shares of OCUL stock, worth $40,136. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,624
Previous 53,456
91.35%
Holding current value
$40,136
Previous $486,000
93.62%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding OCUL
# of Institutions
151Shares Held
136MCall Options Held
86.4KPut Options Held
263K-
Summer Road LLC West Palm Beach, FL14.9MShares$129 Million98.56% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$111 Million9.58% of portfolio
-
Deep Track Capital, LP Greenwich, CT12.7MShares$110 Million2.86% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$100 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.61MShares$74.8 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $668M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...